Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Q172H Replacement Overcomes Effects on the Metabolism of Cyclophosphamide and Efavirenz Caused by CYP2B6 Variant with Arg262

Noritaka Ariyoshi, Miyuki Ohara, Mayumi Kaneko, Sakino Afuso, Takuya Kumamoto, Hiroyoshi Nakamura, Itsuko Ishii, Tsutomu Ishikawa and Mitsukazu Kitada
Drug Metabolism and Disposition November 2011, 39 (11) 2045-2048; DOI: https://doi.org/10.1124/dmd.111.039586
Noritaka Ariyoshi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miyuki Ohara
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mayumi Kaneko
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sakino Afuso
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takuya Kumamoto
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiroyoshi Nakamura
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Itsuko Ishii
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tsutomu Ishikawa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mitsukazu Kitada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 39 no. 11 2045-2048
DOI 
https://doi.org/10.1124/dmd.111.039586
PubMed 
21821736

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received March 16, 2011
  • Accepted August 5, 2011
  • Published online October 18, 2011.

Article Versions

  • Earlier version (August 5, 2011 - 09:51).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2011 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Noritaka Ariyoshi,
  2. Miyuki Ohara,
  3. Mayumi Kaneko,
  4. Sakino Afuso,
  5. Takuya Kumamoto,
  6. Hiroyoshi Nakamura,
  7. Itsuko Ishii,
  8. Tsutomu Ishikawa and
  9. Mitsukazu Kitada
  1. Division of Pharmacy, University Hospital, Chiba University School of Medicine (N.A., H.N., M.Ki.), Department of Clinical Pharmacology (M.O., M.Ka., S.A., I.I.), and Department of Medicinal Organic Chemistry (T.K., T.I.), Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan
  1. Address correspondence to:
    Dr. Noritaka Ariyoshi, Division of Pharmacy, University Hospital, Chiba University School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba 260-8677, Japan. E-mail: ariyoshi{at}faculty.chiba-u.jp
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2011 to January 2021

AbstractFullPdf
Aug 2011288037
Sep 201174013
Oct 2011403844
Nov 20114431628
Dec 2011120711
Jan 20129625
Feb 20125577
Mar 201251210
Apr 201255410
May 20123898
Jun 20123824
Jul 20122623
Aug 20122933
Sep 20123218
Oct 20125356
Nov 2012321016
Dec 2012251411
Jan 2013361310
Feb 2013371110
Mar 2013301416
Apr 2013311216
May 2013232120
Jun 20131898
Jul 2013241710
Aug 201315257
Sep 20133369
Oct 20132273
Nov 20131334
Dec 2013755
Jan 20141622
Feb 2014833
Mar 20141188
Apr 201412145
May 201411810
Jun 2014846
Jul 2014201714
Aug 2014454
Sep 2014954
Oct 201478712
Nov 201415127
Dec 2014964
Jan 20152064
Feb 20151177
Mar 201519189
Apr 201511410
May 20151175
Jun 20151961
Jul 201516610
Aug 20151699
Sep 201514126
Oct 2015850
Nov 2015634
Dec 2015878
Jan 201611717
Feb 2016171011
Mar 201610810
Apr 201620810
May 2016779
Jun 2016758
Jul 20167814
Aug 201617812
Sep 20161364
Oct 20164188
Nov 20166115
Dec 201623810
Jan 20171133
Feb 20170113
Mar 20172517
Apr 2017272
May 2017091
Jun 20170155
Jul 20172157
Aug 20170176
Sep 20170135
Oct 20170205
Nov 20170236
Dec 20171142
Jan 20180153
Feb 2018083
Mar 20181185
Apr 20180267
May 20184246
Jun 20181186
Jul 20180114
Aug 20180145
Sep 20180141
Oct 20181577
Nov 20180614
Dec 201839135
Jan 20196030
Feb 20193116
Mar 20192724
Apr 20191437
May 20191000
Jun 2019539
Jul 20191712
Aug 20192014
Sep 20191721
Oct 20191503
Nov 20192312
Dec 20192662
Jan 20203716
Feb 20201000
Mar 20202804
Apr 20201916
May 20201523
Jun 20201600
Jul 20201110
Aug 2020915
Sep 20201202
Oct 20201503
Nov 2020801
Dec 2020812
Jan 202116123

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 39 (11)
Drug Metabolism and Disposition
Vol. 39, Issue 11
1 Nov 2011
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Q172H Replacement Overcomes Effects on the Metabolism of Cyclophosphamide and Efavirenz Caused by CYP2B6 Variant with Arg262
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

UNIQUE EFFECTS OF Q172H ON CATALYTIC ACTIVITY OF CYP2B6

Noritaka Ariyoshi, Miyuki Ohara, Mayumi Kaneko, Sakino Afuso, Takuya Kumamoto, Hiroyoshi Nakamura, Itsuko Ishii, Tsutomu Ishikawa and Mitsukazu Kitada
Drug Metabolism and Disposition November 1, 2011, 39 (11) 2045-2048; DOI: https://doi.org/10.1124/dmd.111.039586

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

UNIQUE EFFECTS OF Q172H ON CATALYTIC ACTIVITY OF CYP2B6

Noritaka Ariyoshi, Miyuki Ohara, Mayumi Kaneko, Sakino Afuso, Takuya Kumamoto, Hiroyoshi Nakamura, Itsuko Ishii, Tsutomu Ishikawa and Mitsukazu Kitada
Drug Metabolism and Disposition November 1, 2011, 39 (11) 2045-2048; DOI: https://doi.org/10.1124/dmd.111.039586
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Results and Discussion
    • Authorship Contributions
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • BSEP Function in Suspension Hepatocytes
  • Role of AADAC on eslicarbazepine acetate hydrolysis
  • Candesartan glucuronide serves as a CYP2C8 inhibitor
Show more Articles

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics